KRAS and lung carcinoma: The mechanism accounting for the difference in the number of LDs in lung cancer cells is not known at this moment, but the types of driver mutations seem to play a role, as the number of LDs was comparatively higher in all tested KRAS-mutated cells than in EGFR-mutated cells (Figure 3).